ing to 2018 statistics, the incidence of prostate cancer continues to rise, ranking fifth among male cancers (Bray et al., 2018). Despite PCa treatment has made significant progress, advanced PCa still imposes a huge social and economic burden (Cassell et al., 2019).Consequently, exploring new potential biomarkers is essential to discover new treatment strategies for prostate cancer. Circular RNAs (circRNAs) are single-stranded endogenous molecules constructed by back-splicing (Li et al., 2020). CircRNAs with high stability are aberrantly expressed in different diseases and hold great potential as cancer biomarkers (Tang & Hann, 2020). Synchronously, circRNAs are implicated in regulating various biological processes in PCa (Wu et al., 2020). For example, circ_0088233 was prominently boosted in PCa tissues through circRNA microarray detection and exerted oncogenic properties in PCa (Deng et al., 2020).Furthermore, interference of circ-ZNF609 impeded tumour metastasis and increased radiosensitivity in PCa via repressing glycolysis (Du et al., 2020). Also, low levels of circular RNA_LARP4 had apparent correlation with the poor prognosis of PCa patients, and its overexpression alleviated the malignant progression of PCa via combining with FOXO3A (Weng et al., 2020). Besides, prior research revealed that circ_0062019 produced by SLC19A1 gene was conspicuously up-regulated in PCa (Xia et al., 2018). Nevertheless, the mechanism underlying circ_0062019 in PCa needs further inquiry.In terms of circRNAs biological functions, circRNAs block the binding of microRNAs (miRNAs) to downstream target genes through functioning as miRNA sponges (Zhong et al., 2018). For